发明名称 INHIBITION OF HIV-1 REPLICATION BY DISRUPTION OF THE PROCESSING OF THE VIRAL CAPSID-SPACER PEPTIDE 1 PROTEIN
摘要 Inhibition of HIV-1 replication by disrupting the processing of the viral Gag capsid (CA) protein (p24) from the CA-spacer peptide 1 (SP1) protein precursor (p25) is disclosed. Amino acid sequences containing a mutation in the Gag p25 protein, with the mutation resulting in a decrease in the inhibition of processing of p25 to p24 by dimethylsuccinyl betulinic acid or dimethylsuccinyl betulin, polynucleotides encoding such mutated sequences and antibodies that selectively bind such mutated sequences are also included. Methods of inhibiting, inhibitory compounds and methods of discovering inhibitory compounds that target proteolytic processing of the HIV Gag protein are included. In one embodiment, such compounds inhibit the interaction of the HIV protease enzyme with Gag by binding to the Gag proteolytic cleavage site rather than to the protease enzyme. In another embodiment, viruses or recombinant proteins that contain mutations in the region of the Gag proteolytic cleavage site can be used in screening assays to identify compounds that target proteolytic processing.
申请公布号 WO2004069166(A3) 申请公布日期 2005.12.29
申请号 WO2004US02393 申请日期 2004.01.29
申请人 PANACOS PHARMACEUTICALS, INC.;SALZWEDEL, KARL;THE GOVERNMENT OF THE UNITED STATES OF AMERICA, ASREPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;LI, FENG;WILD, CARL, T.;ALLAWAY, GRAHAM, P.;FREED, ERIC, O. 发明人 SALZWEDEL, KARL;LI, FENG;WILD, CARL, T.;ALLAWAY, GRAHAM, P.;FREED, ERIC, O.
分类号 A01N37/02;A01N37/06;A01N37/08;A01N37/10;A01N45/00;A61K;A61K6/00;A61K31/56;A61K38/55;A61K39/42;A61K45/00;A61K45/06;A61M1/14;A61M37/00;A61P31/18;C07K14/155;C07K14/16;C07K16/10;C12N7/00;C12N7/01;C12N15/48;C12P21/02;C12Q1/37;C12Q1/68;C12Q1/70;G01N33/53;G01N33/567;G01N33/569 主分类号 A01N37/02
代理机构 代理人
主权项
地址